N-Methyl-N-ethyltryptamine

Source: Wikipedia, the free encyclopedia.
N-Methyl-N-ethyltryptamine
Names
Preferred IUPAC name
N-Ethyl-2-(1H-indol-3-yl)-N-methylethan-1-amine
Identifiers
3D model (
JSmol
)
ChemSpider
UNII
  • InChI=1S/C13H18N2/c1-3-15(2)9-8-11-10-14-13-7-5-4-6-12(11)13/h4-7,10,14H,3,8-9H2,1-2H3 checkY
    Key: MYEGVMLMDWYPOA-UHFFFAOYSA-N checkY
  • InChI=1/C13H18N2/c1-3-15(2)9-8-11-10-14-13-7-5-4-6-12(11)13/h4-7,10,14H,3,8-9H2,1-2H3
    Key: MYEGVMLMDWYPOA-UHFFFAOYAX
  • c1cccc2c1c(c[nH]2)CCN(CC)C
Properties
C13H18N2
Molar mass 202.295 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)

N-Methyl-N-ethyltryptamine (MET) is a

LSD first developed and characterized by Alexander Shulgin
.

There is very little information on the human pharmacology or toxicity of MET. The freebase is believed to be active via vaporization at 15 mg.[3]

References

  1. PMID 27272067
  2. PMID 28224459
  3. ^ "That's okay, you're good" MET trip report - The Vaults of Erowid

External links


Stub icon

This hallucinogen-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=N-Methyl-N-ethyltryptamine&oldid=1211054447"